Akademska digitalna zbirka SLovenije - logo
VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Procalcitonin in heart failure : hic et nunc
    Cvetinović, Nataša ...
    Although procalcitonin (PCT) was evaluated for the first time in the setting of heart failure (HF) in 1999, its utility in HF patients is still under examination. Patients with HF have significantly ... higher plasma PCT concentrations than healthy subjects and PCT levels are associated with severity of HF. It has been confirmed that higher levels of PCT are associated with worse outcomes, such as increased mortality and higher rate of rehospitalization, in HF patients with no evidence of infection. Furthermore, it has been approved that PCT-guided antibiotic treatment in HF patients reduces duration of antibiotic therapy and improves outcomes. This review summarizes current evidence from the published literature of the usefulness and limitations of PCT as a biomarker in HF.
    Vir: Biomarkers in medicine. - ISSN 1752-0363 (Vol. 11, no. 10, 2017, str. 893-903)
    Vrsta gradiva - članek, sestavni del
    Leto - 2017
    Jezik - angleški
    COBISS.SI-ID - 2814331
    DOI

vir: Biomarkers in medicine. - ISSN 1752-0363 (Vol. 11, no. 10, 2017, str. 893-903)
loading ...
loading ...
loading ...